Goldman Sachs Knock-Out PGR/ DE000GG3KBV2 /
| 2024-06-21 9:54:17 PM | Chg.+0.09 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.21EUR | +8.04% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 220.8238 USD | 2078-12-31 | Put |
GlobeNewswire
06-21
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...
GlobeNewswire
06-21
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 20...
GlobeNewswire
06-21
Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
GlobeNewswire
06-21
XPPen Joins the RSA Schools Art Award 2024, Celebrating the Wonder of Art with the Young Generation
GlobeNewswire
06-21
Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold
GlobeNewswire
06-21
Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndr...
GlobeNewswire
06-21
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and L...
GlobeNewswire
06-21
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDi...
GlobeNewswire
06-13
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
06-12
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
06-12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
06-11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
06-11
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire
06-11
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire
06-10
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
06-10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
06-07
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-07
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
